Multi-site mutagenesis

• US 8,067,556 B2
• Filed: 07/18/2002
• Issued: 11/29/2011
• Est. Priority Date: 07/26/2001
• Status: Expired due to Fees

• Current Assignee: Agilent Technologies, Inc.
• Original Assignee: Agilent Technologies, Inc.
• Inventors: Cline, Janice M., Hogrefe, Holly H.
• Primary Examiner(s): Lu; Frank W
• Application Number:
  US10/198,449
• Publication Number:
  US 20060051748A1
• Time in Patent Office: 3,421 Days
• Field of Search: 435/91.51, 435/91.52, 435/6, 435/91.1, 435/91.2, 435/183, 436/94, 536/23.1, 536/24.3, 536/24.33, 536/25.3
• US Class Current: 536/23.1
• CPC Class Codes: C12N 15/102 Mutagenizing nucleic acids
• CPC Class Codes: C12N 15/1027 by DNA shuffling, e.g. RSR, STEP, RPR
• CPC Class Codes: C12N 9/1252 DNA-directed DNA polymerase (2.7.7.7), i.e. DNA replicase
• CPC Class Codes: C12N 9/22 Ribonucleases RNAses, DNAses catalytic nucleic acids C12N15/113

Abstract

The present invention provides compositions and improved methods for multi-site directed mutagenesis and DNA shuffling. The present compositions and methods provide increased mutation frequency and increased number of transformants which allow one to sequence only a few clones in order to identify the correct mutants and to obtain the desired mutant by screening large number of transformants in a short time. Moreover, the inclusion of FEN-1, PEF and optimized buffer and cycling conditions provided in the present invention should also facilitate random mutagenized library construction and the mutagenesis of large or difficult templates.

Claims

1. An isolated composition comprising a DNA polymerase, a thermostable DNA ligase, a mutagenic primer that is specific for a target polynucleotide, the target polynucleotide, and a flap endonuclease.

2. The isolated composition of claim 1, further comprising a selection enzyme.

3. The isolated composition of claim 2, wherein said selection enzyme is a restriction endonuclease.

4. The isolated composition of claim 3, wherein said restriction endonuclease is methylation-dependent.

5. The isolated composition of claim 4, wherein said methylation-dependent restriction endonuclease is selected from the group consisting of:

DpnI, Nan II, NmuD I, and NmuE I.

6. The isolated composition of claim 1, wherein said DNA polymerase is a thermostable DNA polymerase.

7. The isolated composition of claim 6, wherein said thermostable DNA polymerase is selected from the group consisting of:

Taq DNA polymerase, Pfu DNA polymerase, Tma DNA polymerase, Tli DNA polymerase, KOD DNA polymerase, JDF-3 DNA polymerase, PGB-D DNA polymerase, Tgo DNA polymerase, and Pyrolobus furmarius DNA polymerase.

8. The isolated composition of claim 7, wherein said Pfu-DNA polymerase is Pfu-Turbo DNA polymerase.

9. The isolated composition of claim 1, wherein said thermostable DNA ligase is selected from the group consisting of:

Pfu DNA ligase, Tth DNA ligase, Taq DNA ligase, Thermus filiformis ligase, Rhodothermus marinus DNA ligase, Thermus scotoductus DNA ligase, and Bacillus stearothermophilus DNA ligase.

10. The isolated composition of claim 1, further comprising nicotinamide adenine dinucleotide.

11. The isolated composition of claim 10, wherein said nicotinamide adenine dinucleotide has a concentration from 0.02 mM to 0.2 mM per reaction.

12. The isolated composition of claim 11, wherein said nicotinamide adenine dinucleotide has a concentration of 0.1 mM per reaction.

13. The isolated composition of claim 1, further comprising ATP.

14. The isolated composition of claim 1, wherein said flap endonuclease is a thermostable flap endonuclease.

15. The isolated composition of claim 14, wherein said thermostable endonuclease is selected from the group consisting of:

FEN-1 and Dna2.

20. The isolated composition of claim 1 or 16, further comprising a polymerase enhancing factor.

21. The isolated composition of claim 1 or 16, further comprising DMSO.

22. The isolated composition of claim 1 or 16, further comprising at least one additional primer.

23. The isolated composition of claim 22, wherein said additional primer is a mutagenic primer.

60. The isolated composition of claim 1, 23, or 54, wherein said mutagenic primer is a degenerate primer.

61. The isolated composition of claim 1, 22, 40, or 53, wherein said primer or said additional primer is about 20 to 50 bases in length.

16. An isolated composition comprising Pfu DNA polymerase, a thermostable DNA ligase, a target nucleic acid for mutagenesis, and flap endonuclease.

17. The isolated composition of claim 16, wherein said Pfu DNA polymerase has a concentration from 1.25 U to 2.5 U per 25 μ

l reaction, said DNA ligase has a concentration from 10 U to 20 U per 25 μ

l reaction, and said flap endonuclease has a concentration from 400 ng to 4 μ

g per 25 μ

l reaction.

18. The isolated composition of claim 17, further comprising 0.01 mM to 0.2 mM nicotinamide adenine dinucleotide per the reaction.

19. The isolated composition of claim 18, wherein the DNA ligase is Taq DNA ligase and wherein the concentration of said Pfu DNA polymerase is 2.5 U per 25 μ

l reaction, the concentration of said Taq DNA ligase is 15 U per 25 μ

l reaction, the concentration of said flap endonuclease is 400 ng per 25 μ

l reaction, and the concentration of said nicotinamide adenine dinucleotide is 0.1 mM per 25 μ

l reaction.

24. A kit comprising a DNA polymerase, a thermostable DNA ligase, a flap endonuclease, a restriction endonuclease, a mutagenic primer that is specific for a target polynucleotide, a control template nucleic acid, and packaging means therefor.

25. The kit of claim 24, further comprising a selection enzyme.

26. The kit of claim 24, wherein said DNA polymerase is Pfu DNA polymerase.

27. The kit of claim 24, wherein said DNA ligase is a Taq DNA ligase.

28. The kit of claim 24, further comprising nicotinamide adenine dinucleotide at a concentration from 0.01 to 0.2 mM per reaction.

29. The kit of claim 24, wherein said flap endonuclease is FEN-1.

30. A kit comprising Pfu DNA polymerase, Taq DNA ligase, a mutagenic primer that is specific for a target polynucleotide, a control template nucleic acid, and FEN-1.

31. The isolated composition of claim 30, wherein said Pfu DNA polymerase has a concentration from 1.25 U to 2.5 U per 25 μ

l reaction, said DNA ligase has a concentration from 10 U to 20 U per 25 μ

l reaction, and said flap endonuclease has a concentration from 400 ng to 4 μ

g per 25 μ

l reaction.

32. The kit of claim 31, further comprising 0.01 to 0.2 mM nicotinamide adenine dinucleotide per the reaction.

33. A kit comprising 2.5 U Pfu DNA polymerase, 15 U Taq DNA ligase, 400 ng flap endonuclease, and 0.1 mM nicotinamide adenine dinucleotide per 25 μ

l reaction.

34. The kit of claim 33, further comprising a selection enzyme, which is a restriction endonuclease.

35. The kit of claim 34, wherein said restriction endonuclease is selected from the group consisting of:

DpnI, Nan II, NmuD I, and NmuE I.

36. The kit of claim 33, further comprising at least one mutagenic primer.

37. An isolated composition comprising a DNA polymerase, a thermostable DNA ligase, a restriction endonuclease, a target nucleic acid for mutagenesis, and a flap endonuclease.

38. The isolated composition of claim 37, wherein said restriction endonuclease is methylation-dependent.

39. The isolated composition of claim 38, wherein said methylation-dependent restriction endonuclease is selected from the group consisting of:

DpnI, Nan II, NmuD I, and NmuE I.

40. The isolated composition of claim 37, further comprising at least one primer.

41. The isolated composition of claim 40, wherein said primer is a mutagenic primer.

42. The isolated composition of claim 41, wherein said mutagenic primer is a degenerate primer.

43. An isolated composition comprising a DNA polymerase, a thermostable DNA ligase, a selection enzyme, a parental target DNA, and a flap endonuclease, wherein said selection enzyme selectively digests the parental target DNA.

44. The isolated composition of claim 43, wherein said DNA polymerase is a thermostable DNA polymerase.

45. The isolated composition of claim 44, wherein said thermostable DNA polymerase is selected from the group consisting of:

Taq DNA polymerase, Pfu DNA polymerase, Tma DNA polymerase, Tli DNA polymerase, KOD DNA polymerase, JDF-3 DNA polymerase, PGB-D DNA polymerase, Tgo DNA polymerase, and Pyrolobus funnarius DNA polymerase.

46. The isolated composition of claim 43, wherein said thermostable DNA ligase is selected from the group consisting of:

Pfu DNA ligase, Tth DNA ligase, Taq DNA ligase, Thermus filiformis ligase, Rhodothermus marinus DNA ligase, Thermus scotoductus DNA ligase, and Bacillus stearothermophilus DNA ligase.

47. The isolated composition of claim 43, further comprising nicotinamide adenine dinucleotide.

48. The isolated composition of claim 43, wherein said flap endonuclease is a thermostable flap endonuclease.

49. The isolated composition of claim 48, wherein said thermostable endonuclease is selected from the group consisting of:

FEN-1 and Dna2.

50. The isolated composition of claim 43, wherein said selection enzyme is a restriction endonuclease.

51. The isolated composition of claim 50, wherein said restriction endonuclease is methylation-dependent.

52. The isolated composition of claim 51, wherein said methylation-dependent restriction endonuclease is selected from the group consisting of:

DpnI, Nan II, NmuD I, and NmuE I.

53. The isolated composition of claim 43, further comprising at least one primer.

54. The isolated composition of claim 53, wherein said primer is a mutagenic primer.

55. An isolated composition comprising a DNA polymerase, a thermostable DNA ligase, RecJ exonuclease, a target polynucleotide, and a mutagenic primer that is specific for the target polynucleotide.

56. The isolated composition of claim 55, further comprising a selection enzyme.

57. The isolated composition of claim 56, wherein said selection enzyme is a restriction endonuclease.

58. The isolated composition of claim 57, wherein said restriction endonuclease is methylation-dependent.

59. The isolated composition of claim 58, wherein said methylation-dependent restriction endonuclease is selected from the group consisting of:

DpnI, Nan II, NmuD I, and NmuE I.